These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15342194)

  • 1. ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity.
    Scott GS; Kean RB; Fabis MJ; Mikheeva T; Brimer CM; Phares TW; Spitsin SV; Hooper DC
    J Neuroimmunol; 2004 Oct; 155(1-2):32-42. PubMed ID: 15342194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.
    Hooper DC; Scott GS; Zborek A; Mikheeva T; Kean RB; Koprowski H; Spitsin SV
    FASEB J; 2000 Apr; 14(5):691-8. PubMed ID: 10744626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity.
    Kean RB; Spitsin SV; Mikheeva T; Scott GS; Hooper DC
    J Immunol; 2000 Dec; 165(11):6511-8. PubMed ID: 11086092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
    Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.
    Fabis MJ; Phares TW; Kean RB; Koprowski H; Hooper DC
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15511-6. PubMed ID: 18829442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent.
    Hooper DC; Kean RB; Scott GS; Spitsin SV; Mikheeva T; Morimoto K; Bette M; Röhrenbeck AM; Dietzschold B; Weihe E
    J Immunol; 2001 Sep; 167(6):3470-7. PubMed ID: 11544340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.
    Spitsin S; Portocarrero C; Phares TW; Kean RB; Brimer CM; Koprowski H; Hooper DC
    J Neuroimmunol; 2008 May; 196(1-2):8-15. PubMed ID: 18406473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
    Stanislaus R; Singh AK; Singh I
    J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
    Chaudhary P; Marracci GH; Bourdette DN
    J Neuroimmunol; 2006 Jun; 175(1-2):87-96. PubMed ID: 16644024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid.
    Spitsin SV; Scott GS; Kean RB; Mikheeva T; Hooper DC
    Neurosci Lett; 2000 Oct; 292(2):137-41. PubMed ID: 10998568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase.
    Martínez I; Puerta C; Redondo C; García-Merino A
    J Neurol Sci; 1999 Mar; 164(1):13-23. PubMed ID: 10385042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops.
    Freyer D; Manz R; Ziegenhorn A; Weih M; Angstwurm K; Döcke WD; Meisel A; Schumann RR; Schönfelder G; Dirnagl U; Weber JR
    J Immunol; 1999 Oct; 163(8):4308-14. PubMed ID: 10510370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells.
    Tsang CM; Wong CK; Ip WK; Lam CW
    J Leukoc Biol; 2005 Jul; 78(1):239-47. PubMed ID: 15800027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
    Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
    Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.
    Scott GS; Spitsin SV; Kean RB; Mikheeva T; Koprowski H; Hooper DC
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16303-8. PubMed ID: 12451183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier.
    Dietrich JB
    J Neuroimmunol; 2002 Jul; 128(1-2):58-68. PubMed ID: 12098511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
    Liu Y; Zhu B; Wang X; Luo L; Li P; Paty DW; Cynader MS
    J Neuroimmunol; 2003 Jun; 139(1-2):27-35. PubMed ID: 12799017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient.
    Phares TW; Fabis MJ; Brimer CM; Kean RB; Hooper DC
    J Immunol; 2007 Jun; 178(11):7334-43. PubMed ID: 17513784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.